Nykode Therapeutics AS (OSL:NYKD)
Norway
· Delayed Price · Currency is NOK 2.438
+0.118 (5.09%)
At close: Dec 5, 2025
Nykode Therapeutics AS Revenue
Nykode Therapeutics AS had revenue of $118.00K USD in the quarter ending September 30, 2025, a decrease of -82.26%. This brings the company's revenue in the last twelve months to $7.35M, up 68.10% year-over-year. In the year 2024, Nykode Therapeutics AS had annual revenue of $9.16M, down -31.26%.
Revenue (ttm)
$7.35M
Revenue Growth
+68.10%
P/S Ratio
10.85
Revenue / Employee
$54.01K
Employees
136
Market Cap
796.12M NOK
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.16M | -4.17M | -31.26% |
| Dec 31, 2023 | 13.32M | 4.29M | 47.56% |
| Dec 31, 2022 | 9.03M | -26.74M | -74.76% |
| Dec 31, 2021 | 35.77M | -179.93M | -83.42% |
| Dec 31, 2020 | 215.70M | 214.28M | 15,175.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 662.18M |
| Nordhealth AS | 590.33M |
| Photocure ASA | 537.59M |
| ArcticZymes Technologies ASA | 109.99M |
| Omda AS | 476.29M |
| Vistin Pharma ASA | 455.25M |
| Gentian Diagnostics ASA | 172.52M |
| Lytix Biopharma AS | 377.00K |
Nykode Therapeutics AS News
- 11 days ago - Nykode Therapeutics AS 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 11 days ago - Q3 2025 Nykode Therapeutics ASA Earnings Call Transcript - GuruFocus